23&Me, for instance, only tests for 44 genetic variants in the BRCA1 and BRCA2 genes, which suggest a proneness to breast cancer, but there are more than 4,000 known variants that increase the risk.

The task force identified fair evidence that, without substantial family histories, women are at low risk for developing BRCA-mutation ... so that appropriate genetic testing can be recommended.

Ounce of Prevention is a weekly column which presents recommendations for preventative services derived from The United ...

acting as a 'pre-screen' for BRCA mutations (BRCAm) that can then be confirmed with a regular genetic test. The germline BRCA (gBRCA) pre-screen programme has grown out of Owkin's ongoing ...

The main indications for the non-BRCA patients to receive genetic testing included a personal history of breast cancer (51%) or a positive family history (27%). The risk-reducing surgeries that ...

The experience of millions of women who received BRCA testing showed the world how democratizing genetic data can concretely benefit health outcomes. 23andMe’s participant-driven model ...

With cancer cases projected to rise by 77% to 35 million by 2050, understanding genetic predisposition has become increasingly important. In India, where one in nine people is projected to face a ...

A woman who discovered she had breast cancer after a chance reading of a newspaper article is warning others with Jewish heritage of the increased risk. | ITV News Central ...